JPRN-UMIN000001660
Completed
Phase 2
Phase II trial of neo-adjuvant chemohormonal therapy combining LHRH agonist and estramustine phosphate evaluating PSA failure free survival and safety for locally advanced prostate cancer - Phase II trial of neo-adjuvant chemohormonal therapy combining LHRH agonist and estramustine phosphate evaluating PSA failure free survival and safety for locally advanced prostate cancer
Hirosaki University Graduate School of Medicine0 sites50 target enrollmentJanuary 27, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hirosaki University Graduate School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)patients with severe co\-morbidity including uncontrollable cardiac, cerebral disease. 2\)patients with serious liver dysfunction or serious blood disease. 3\)patients with gastroenterial ulcer. 4\)Patients who had hypersensitivity to Goserelin or Leuprorelin. 5\)patients who fall under the followings: AST, ALT and ALP \> 2\.5 times upper limit of normal (ULN), Serum creatinine \> 1\.5 times ULN , Leukocyte count \< 3,000/uL, Hemoglobin \< 10\.0g/dL, Platelet count \< 75,000/uL 6\)Patients with other cancer requiring treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigation of neoadjuvant chemohormonal therapy before robot-assisted radical prostatectomy for the patients with high-risk prostate cancer.JPRN-UMIN000034906Tottori University Hospital100
Recruiting
Phase 2
Investigation of neoadjuvant chemohormonal therapy before robot-assisted radical prostatectomy for the patients with high-risk prostate cancer.JPRN-jRCTs061180057Takenaka Atsushi100
Recruiting
Phase 2
Phase II multicenter trial of neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant chemotherapy by irrinotecan hydrochloride and nedaplatin for the patients with stage Ib2-IIb bulky cervical cancer (tumor diameter > 4 cm): OGSK_KCOG-G1201JPRN-UMIN000008023The Obstetrical and Gynecological Society of Kinki District Japan and the Kansai Clinical Oncology Group68
Active, not recruiting
Phase 1
Study of chemotherapy and immunotherapy before and after surgery inpatients with non-small cell lung cancer whose tumor is located in theupper part of the lungsCTIS2024-512359-19-00Fundacion GECP40
Completed
Phase 2
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancerIncasive ductal carcinoma of pancreas with macroscopic complete resectionJPRN-UMIN000002000Chiba study group of adjuvant chemotherapy for pancreatic cancer96